CIK 0001799788
- Non-accelerated filer
- Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205473709
- Phone
- +1 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-21 | Hallock Kenneth Director | Purchase | +300 | $16.32 | $5K | 397,304 |
| 2022-01-18 | Thompson Jaye VP Clinical Reg. Affairs | Purchase | +500 | $18.87 | $9K | 254,495 |
| 2022-01-13 | Patel Snehal CEO and CFO | Purchase | +1,000 | $19.99 | $20K | 1,194,429 |
| 2022-01-13 | Thompson Jaye VP Clinical Reg. Affairs | Purchase | +1,000 | $19.99 | $20K | 253,995 |
| 2022-01-13 | Daugherty Frank Joseph Chief Medical Officer | Purchase | +1,000 | $19.99 | $20K | 89,121 |
| 2022-01-03 | Patel Snehal CEO and CFO | Purchase | +2,050 | $23.82 | $49K | 1,193,429 |
| 2021-12-14 | Patel Snehal CEO and CFO | Purchase | +1,840 | $27.17 | $50K | 1,191,379 |
| 2021-12-14 | Daugherty Frank Joseph Chief Medical Officer | Purchase | +1,111 | $26.99 | $30K | 88,121 |
| 2021-12-14 | McWilliams David Director | Purchase | +200 | $27.56 | $6K | 620,301 |
| 2021-04-13 | Patel Snehal CEO and CFO | Purchase | +2,700 | $36.98 | $100K | 1,189,539 |
| 2020-11-24 | Hallock Kenneth Director | Purchase | +1,000 | $5.39 | $5K | 397,004 |
| 2020-11-23 | Daugherty Frank Joseph Chief Medical Officer | Purchase | +1,000 | $5.10 | $5K | 87,010 |
| 2020-11-20 | Hallock Kenneth Director | Purchase | +1,000 | $5.37 | $5K | 396,004 |
| 2020-11-20 | McWilliams David Director | Purchase | +1,500 | $5.40 | $8K | 620,101 |
| 2020-11-20 | Rothe Eric Director | Purchase | +2,000 | $5.40 | $11K | 313,226 |
| 2020-11-19 | Patel Snehal CEO and CFO | Purchase | +2,000 | $5.40 | $11K | 1,186,839 |
| 2020-09-29 | Patel Snehal CEO and CFO | Purchase | +16,667 | $4.60 | $77K | 1,184,839 |
| 2020-09-29 | Hallock Kenneth Director | Purchase | +8,333 | $4.60 | $38K | 395,004 |
| 2020-09-29 | Hallock Kenneth Director | Purchase | +74,782 | $5.75 | $430K | 257,368 |
| 2020-09-29 | Patel Snehal CEO and CFO | Purchase | +114,347 | $5.75 | $657K | 863,683 |
Page 6 of 7 · 122 trades